Conditions: Chronic Urticaria
Keywords: Chronic Idiopathic Urticaria CIU Urticaria Chronic Hives Xolair
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 10
Healthy volunteers: no

Brief summary:
This study looks at changes in cell proteins in people with chronic hives treated with omalizumab.

Detailed description:
The purpose of this study is to evaluate for changes in the proteins produced in white blood cells (basophils) in patients with chronic hives who are treated with and respond to omalizumab.

Arms:
arm 1: Patients will receive omalizumab 300mg subcutaneously every 4 weeks for 12 weeks at the study center.

Interventions: intervention 1: Omalizumab
Intervention descriptions: intervention 1: Patients will receive omalizumab 300mg subcutaneously every 4 weeks for 12 weeks at the study center.

Protocol document: